GlaxoSmithkline Consumer Healthcare (GSKCH) is trading higher by 3% at Rs 3,084 after reporting 25% year-on-year (yoy) jump in net profit at Rs 129 crore for the third quarter ended September 30. Net sales grew 15% at Rs 828 crore on y-o-y basis.
Commenting on the results GSKCH Managing Director Zubair Ahmed said: "The strong results in the third quarter are backed by innovation and strong leveraging of science that has helped us come up with a winning proposition on our flagship brand Horlicks", the PTI report suggest.
The stock opened at Rs 3,050 and touched high of Rs 3,142 on the BSE. A combined 9,424 shares have changed hands on the counter so far on both the exchanges.
